Previous reports with aminoglutethimide, an AI, also showed an increase in aromatase activity in breast cancer cell line SK-BR-3, choriocarcinoma cell line JAR, and in hepatocellular carcinoma HepG2 [30]. The gene discussed is CYP19A1; the disease is hepatocellular carcinoma.